title: [Predominant central vestibular symptomatology caused by carbamazepine and dextropropoxyphene interaction].
authors.forename: P
authors.initials: P
authors.lastname: Bertholon
authors.forename: P
authors.initials: P
authors.lastname: Convers
authors.forename: N
authors.initials: N
authors.lastname: Lachheb
authors.forename: C
authors.initials: C
authors.lastname: Guy
authors.forename: C
authors.initials: C
authors.lastname: Martin
authors.forename: M
authors.initials: M
authors.lastname: Ollagnier
authors.forename: D
authors.initials: D
authors.lastname: Michel
mesh_terms: D000328:Adult; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D000701:Analgesics, Opioid / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects*; D011431:Dextropropoxyphene / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015837:Vestibular Diseases / Q000139:chemically induced*
chemical_list: D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D002220:Carbamazepine; D011431:Dextropropoxyphene
vernacular_title: Sémiologie vestibulaire centrale prépondérante par interaction carbamazépine et dextropropoxyphène.